MERSANA THERAPEUTICS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 22233
 
  
 
C08G MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS 9111
 
  
 
C07K PEPTIDES 8128
 
  
 
C08L COMPOSITIONS OF MACROMOLECULAR COMPOUNDS 4112
 
  
 
C07D HETEROCYCLIC COMPOUNDS 2160
 
  
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 1139
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 1137
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 1166

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0313,778 MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOFJul 14, 17Nov 02, 17[A61K, C07K]
2017/0266,311 NaPi2b-targeted Antibody-Drug Conjugates and Methods of Use ThereofMar 13, 17Sep 21, 17[A61K, C07K, C08L]
2017/0119,896 TERMINALLY MODIFIED POLYMERS AND CONJUGATES THEREOFSep 08, 16May 04, 17[A61K, C08G, C07K]
2015/0104,407 PROTEIN-POLYMER-DRUG CONJUGATESOct 10, 14Apr 16, 15[A61K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9872918 Hydroxyl-polymer-drug-protein conjugatesDec 12, 13Jan 23, 18[A61K, C07K]
9849191 Protein-polymer-drug conjugatesOct 10, 14Dec 26, 17[A61K]
9808528 Protein-polymer-drug conjugates and methods of using sameJun 18, 15Nov 07, 17[A61K, A61P]
9770519 Protein-polymer-drug conjugatesAug 24, 15Sep 26, 17[A61K, C08G, C08L]
9738720 Monoclonal antibodies against HER2 epitope and methods of use thereofNov 04, 16Aug 22, 17[A61K, C07K]
9555112 Monoclonal antibodies against HER2 epitope and methods of use thereofJun 18, 15Jan 31, 17[A61K, C07K]
9254339 Protein-polymer-drug conjugatesAug 12, 14Feb 09, 16[A61K, C08G, C07K]
9144615 Protein-polymer-drug conjugatesAug 12, 14Sep 29, 15[A61K, C08G]
8821850 Protein-polymer-drug conjugatesJan 16, 14Sep 02, 14[A61K, C08G]
8815226 Protein-polymer-drug conjugatesDec 10, 12Aug 26, 14[A61K, C08G]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0022,829 TUBULYSIN COMPOUNDS AND CONJUGATES THEREOFAbandonedMar 13, 14Jan 28, 16[A61K, C08G]
2014/0017,265 Terminally Modified Polymers and Conjugates ThereofAbandonedJul 03, 13Jan 16, 14[A61K]
2014/0004,074 Pharmaceutical Formulations of Biodegradable Biocompatible Camptothecin-Polymer ConjugatesAbandonedJun 18, 13Jan 02, 14[A61K]
2013/0189,218 PHARMACEUTICAL FORMULATIONS FOR FUMAGILLIN DERIVATIVE-PHF CONJUGATESAbandonedDec 21, 12Jul 25, 13[A61K]
8491880 Pharmaceutical formulations of biodegradable biocompatible camptothecin-polymer conjugatesExpiredDec 10, 09Jul 23, 13[A61K]
2013/0158,046 BIOCOMPATIBLE BIODEGRADABLE FUMAGILLIN ANALOG CONJUGATESAbandonedFeb 15, 13Jun 20, 13[C07D]
2013/0109,817 Modified Polymers for Delivery of Polynucleotides, Method of Manufacture, and Methods of Use ThereofAbandonedJan 07, 13May 02, 13[C08G]
8399512 Biocompatible biodegradable fumagillin analog conjugatesExpiredNov 24, 08Mar 19, 13[A61K, C07D]
8349308 Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereofExpiredMar 28, 11Jan 08, 13[A61K, C07H, C12N]
2011/0044,967 Conjugates Comprising a Biodegradable Polymer and Uses ThereforAbandonedAug 27, 10Feb 24, 11[A61K, C12N]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.